GT Biopharma Appoints Michael Handelman, CPA as Chief Financial Officer

BEVERLY HILLS, CA / ACCESSWIRE / November 18, 2020 / GT Biopharma,…

GT Biopharma Announces Former Abraxis CEO, Bruce J. Wendel as Vice Chairman of GTBP Board of Directors

BEVERLY HILLS, CA / ACCESSWIRE / November 17, 2020 / PGT Biopharma,…

GT Biopharma Announces Expanded TriKE(TM) Partnership With Cytovance Biologics

Sign $6,000,000.00 Agreement BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020…

Investors Are Scrambling To Get Ahead Of The Oncology Drug Market Boom; 1 Company Could Revolutionize The Industry

Designer Cancer Treatments Are The Next Opportunity For Investors; 1 Company Set To Pave The Way

GT Biopharma Announces GTB-3550 TriKE(TM) Phase I/II Clinical Trial Update

BEVERLY HILLS, CA / ACCESSWIRE / September 22, 2020 / GT Biopharma,…

Algernon Receives First Ethics Approval for Phase 2 Ifenprodil IPF and Chronic Cough Human Study in Australia

VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…